| Literature DB >> 30733469 |
Noushin Sadat Ahanchi1,2, Farzad Hadaegh1, Abbas Alipour3, Arash Ghanbarian1, Fereidoun Azizi4, Davood Khalili5,6.
Abstract
In this study, using latent class analysis (LCA), we investigated whether there are any homogeneous subclasses of individuals exhibiting different profiles of metabolic syndrome (MetS) components. The current study was conducted within the framework of the Tehran Lipid and Glucose Study (TLGS), a population-based cohort including 6448 subjects, aged 20-50 years. We carried out a LCA on MetS components and assessed the association of some demographic and behavioral variables with membership of latent subclasses using multinomial logistic regression. Four latent classes were identified:(1) Low riskclass, with the lowest probabilities for all MetS components (its prevalence rate in men: 29%, women: 64.7%), (2) MetS with diabetes medication (men: 1%, women: 2.3%), (3) Mets without diabetes medication (men: 32%, women: 13.4%), (4) dyslipidemia (men: 38%, women: 19.6%). In men the forth subclass was more significantly associated with being smoker (odds ratio: 4.49; 95% CI: 1.89-9.97). Our study showed that subjects with MetS could be classified in sub-classes with different origins for their metabolic disorders including drug treated diabetes, those with central obesity and dyslipidemia associated with smoking.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30733469 PMCID: PMC6367385 DOI: 10.1038/s41598-018-38095-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Sample characteristics (N = 6448).
| Variables | Men (n = 2597) Mean (SD) or proportion | Women (n = 3851) Mean (SD) or proportion | P value |
|---|---|---|---|
|
| |||
| Age (years) | 34.2 (8.2) | 33.9 (8.40) | 0.130 |
| Smoking status (current) (%) | 32 | 4.2 | 0.001 |
| Education (greater than diploma) (%) | 21 | 11.7 | <0.0001 |
| Marital status (single) (%) | 27.1 | 16.6 | <0.0001 |
| Low Physical activity (%) | 78 | 72.7 | <0.0001 |
| Glucose (mmol/dl) | 5.13 (1.11) | 5.08 (1.33) | 0.007 |
| Systolic blood pressure (mm Hg) | 114.7 (12.7) | 112.2 (13.6) | <0.0001 |
| Diastolic blood pressure (mm Hg) | 76.2 (10.07) | 75.9 (9.6) | <0.0001 |
| HDL cholesterol (mmol/dl) | 0.98 (0.23) | 1.15 (0.28) | <0.0001 |
| Triglycerides (mmol/dl) | 1.70 (1.14–2.51)* | 1.31 (0.91–1.97)* | <0.0001 |
| Waist circumference (cm) | 86.6 (11.3) | 84.5 (12.3) | <0.0001 |
|
| |||
| High glucose (%) | 15.4 | 14 | 0.110 |
| High triglyceride (%) | 50.4 | 34.3 | <0.0001 |
| High waist (%) | 24.2 | 21.3 | 0.007 |
| LowHDL (%) | 65.6 | 75 | <0.0001 |
| High blood pressure (%) | 23.2 | 19.6 | <0.0001 |
| Antihypertensive medication (%) | 0.8 | 2.7 | <0.0001 |
| Lipid-lowering medication (%) | 1 | 1.4 | <0.0001 |
| Diabetes medication (%) | 1 | 1.5 | <0.0001 |
| Mets | 40.0 | 28.2 | <0.0001 |
*Expressed as median (interquartile range).
Estimated prevalence of latent classes and the probability of observed metabolic syndrome components for each subclass.
| Low risk | MetS with diabetes medication | MetS without diabetes medication | Dyslipidemia | |
|---|---|---|---|---|
|
|
|
|
|
|
|
| ||||
| high glucose | 0.06 |
| 0.41 | 0.16 |
| High waist | 0.09 | 0.47 |
| 0.29 |
| low HDL | 0.61 |
|
|
|
| High triglyceride | 0.09 |
|
|
|
| High blood pressure | 0.11 | 0.46 |
| 0.22 |
| Lipid-lowering medication | 0.00 | 0.17 | 0.04 | 0.01 |
| Diabetes medication | 0.00 |
| 0.00 | 0.00 |
| Antihypertensive medication | 0.00 | 0.19 | 0.08 | 0.006 |
Estimated prevalence of latent classes and the probability of observed metabolic syndrome components for each subclass in men and women.
| C1 (Low risk) | C2 (MetS with diabetes medication) | C3 (MetS without diabetes medication) | C4 (Dyslipidemia) | |
|---|---|---|---|---|
|
| ||||
| Men (%) |
|
|
|
|
| Women (%) |
|
|
|
|
|
| ||||
| Men | ||||
| high glucose |
|
| 0.29 | 0.05 |
| High waist |
| 0.44 |
| 0.09 |
| low HDL |
|
|
|
|
| High triglyceride |
|
|
| 0.42 |
| High blood pressure |
| 0.36 | 0.41 | 0.10 |
| Lipid-lowering medication |
| 0.12 | 0.02 | 0.00 |
| Diabetes medication |
|
| 0.00 | 0.00 |
| Antihypertensive medication |
| 0.04 | 0.01 | 0.00 |
| Women | ||||
| High glucose |
|
| 0.39 | 0.16 |
| High waist |
|
|
| 0.29 |
| LowHDL |
|
|
|
|
| High triglyceride |
|
|
|
|
| High blood pressure |
|
|
| 0.23 |
| Lipid-lowering medication |
| 0.20 | 0.02 | 0.02 |
| Diabetes medication |
|
| 0.00 | 0.00 |
| Antihypertensive medication |
| 0.25 | 0.10 | 0.01 |
The characteristics of individuals and the proportion of the MetS components in different subclasses.
| Men | Low risk (n = 799) | MetS with diabetes medication (n = 25) | MetS without diabetes medication (n = 738) | Dyslipidemia (n = 1035) | P value |
|---|---|---|---|---|---|
| Age (years) | 32.55(8.41) | 42.76(7.40) | 37.12(7.48) | 33.22(8.09) | <0.0001 |
| Smoking status (Current), n (%) | 26.8 | 32.0 | 33.3 | 35.1 | <0.0001 |
| High glucose | 10.9 | 100 | 34.8 | 3.0 | <0.0001 |
| High waist | 9.5 | 44.0 | 65.4 | 5.6 | <0.0001 |
| Low HDL | 0.0 | 76.0 | 87.9 | 100 | <0.0001 |
| High triglyceride | 21.5 | 60.0 | 94.3 | 41.3 | <0.0001 |
| High blood pressure | 20.2 | 36.0 | 50.0 | 6.1 | <0.0001 |
| Antihypertensive medication use (%) | 0.1 | 4.0 | 2.0 | 3.0 | <0.0001 |
| Lipid-lowering medication use (%) | 0.1 | 12.0 | 2.8 | 2.0 | <0.0001 |
| Glucose-lowering medication use (%) | 0.0 | 100 | 0.0 | 0.0 | <0.0001 |
| Mets | 16.0 | 0.68 | 98.8 | 15.9 | <0.0001 |
| Insulin resistance (%) | 9.0 | 70.0 | 43.0 | 11.3 | <0.0001 |
|
|
|
|
|
|
|
| Age (years) | 31.48 (7.96) | 42.93 (4.74) | 40.22 (6.69) | 36.75 (7.54) | <0.0001 |
| Smoking status (Current), n (%) | 3.9 | 9.1 | 3.8 | 4.8 | <0.0001 |
| High glucose | 4.7 | 97.2 | 42.8 | 18.8 | <0.0001 |
| High waist | 8.1 | 51.5 | 82.9 | 25.4 | <0.0001 |
| Low HDL | 65.4 | 87.9 | 70.8 | 100 | <0.0001 |
| High triglyceride | 2.4 | 75.8 | 60.1 | 100 | <0.0001 |
| High blood pressure | 8.6 | 50.0 | 79.3 | 18.8 | <0.0001 |
| Antihypertensive medication use (%) | 7.0 | 27.3 | 14.7 | 8.0 | <0.0001 |
| Lipid-lowering medication use (%) | 1.0 | 28.2 | 3.1 | 1.9 | <0.0001 |
| Glucose-lowering medication use (%) | 0.0 | 89.4 | 0.0 | 0.0 | <0.0001 |
| Mets | 2.0 | 93.9 | 82.8 | 30.2 | <0.0001 |
| Insulin resistance (%) | 11.9 | 80.7 | 43.6 | 31.9 | <0.0001 |
*We considered a HOMA-IR more than 2.38 in men and 2.68 in women as indicating the presence of Insulin resistance. The number of participants with available insulin data was 2785 (1749 men).
Associations between latent class membership with demographic and lifestyle variables.
| Predictors | Low risk (REF.) | MetS with diabetes medication Odds (95% CI) | MetS without diabetes medication Odds (95% CI) | Dyslipidemia Odds (95% CI) |
|---|---|---|---|---|
|
|
|
|
|
|
| Age (year) | REF | 1.26 (1.19–1.32)* | 1.20 (1.14–1.25)* | 1.11 (1.07–1.15)* |
| Education (diploma and higher) | REF. | 0.509 (0.15–1.64) | 1.059 (0.77–1.43) | 0.942 (0.72–1.21) |
| Low Physical activity | REF. | 0.96 (0.38–2.46) | 1.42 (1.04–1.94)* | 0.95 (0.74–1.22) |
| Smoking status (Current) | REF. | 2.270 (0.74–6.68) | 2.30 (0.97–5.44) | 4.49 (1.89–9.97)* |
|
|
|
|
|
|
| age | REF. | 1.40 (1.33–1.46)* | 1.33 (1.23–1.43)* | 1.17 (1.13–1.20)* |
| Education (diploma and higher) | REF. | 0.306 (0.04–2.29) | 0.150 (0.02–1.09) | 0.430 (0.20–0.91)* |
| Low Physical activity | REF. | 0.67 (0.39–1.16) | 1.19 (0.80–1.7) | 1.15 (0.87–1.50) |
| Smoking status (Current) | REF. | 2.688 (1.08–6.61)* | 0.539 (0.27–10.4) | 1.332 (0.77–2.29) |
Associations between latent class memberships with HOMA_IR variable.
| Predictor | Low risk (REF.) | MS with diabetes medication Odds (95% CI) | MS without diabetes medication Odds (95% CI) | Dyslipidemia Odds (95% CI) |
|---|---|---|---|---|
|
| ||||
| HOMA_IR | REF | 2.35 (1.98–2.80) | 2.06 (1.81–2.33) | 1.79 (1.61–1.99) |
| HOMA_IR | 0.13(0.08–0.20) | REF | 0.67 (0.52–0.88) | 0.17 (0.12–0.25) |
|
| ||||
| HOMA_IR | REF | 3.71 (2.82–4.86) | 2.88 (2.32–3.56) | 1.19 (0.97–1.46 |
| HOMA_IR | 0.26 (0.20–0.34) | REF | 0.81 (0.65–1.01) | 0.65 (0.51–0.83) |